%20--%3e%3c!DOCTYPE%20svg%20PUBLIC%20'-//W3C//DTD%20SVG%201.1//EN'%20'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'%20[%20%3c!ENTITY%20st0%20'fill:%23267E9A;'%3e%3c!ENTITY%20st1%20'fill:%2378C9DA;'%3e%3c!ENTITY%20st2%20'fill:%23FFFFFF;'%3e%3c!ENTITY%20st3%20'fill:%23085580;'%3e%3c!ENTITY%20st4%20'fill:%2386C34A;'%3e%3c!ENTITY%20st5%20'fill:%232FBBCC;'%3e%3c!ENTITY%20st6%20'fill:%234C6F90;'%3e%3c!ENTITY%20st7%20'fill:%23194670;'%3e%3c!ENTITY%20st8%20'fill:%2307557E;'%3e%3c!ENTITY%20st9%20'fill:%23516E89;'%3e%20]%3e%3csvg%20version='1.1'%20id='Layer_1'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%2032%2032'%20style='enable-background:new%200%200%2032%2032;'%20xml:space='preserve'%3e%3cg%3e%3cg%3e%3crect%20x='10.3'%20y='14'%20style='&st5;'%20width='5'%20height='4.4'/%3e%3crect%20x='10.3'%20y='12'%20style='&st5;'%20width='11.4'%20height='1'/%3e%3crect%20x='16.4'%20y='14'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='15.8'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='17.5'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='19.3'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='10.3'%20y='19.3'%20style='&st5;'%20width='5'%20height='0.9'/%3e%3cg%3e%3cpath%20style='&st5;'%20d='M22.6,22.3H9.4c-0.6,0-1.2-0.5-1.2-1.2v-10c0-0.6,0.5-1.2,1.2-1.2h13.1c0.6,0,1.2,0.5,1.2,1.2v10%20C23.7,21.7,23.2,22.3,22.6,22.3z%20M9.4,10.8c-0.1,0-0.3,0.1-0.3,0.3v10c0,0.1,0.1,0.3,0.3,0.3h13.1c0.1,0,0.3-0.1,0.3-0.3v-10%20c0-0.1-0.1-0.3-0.3-0.3H9.4z'/%3e%3c/g%3e%3c/g%3e%3cpath%20style='&st5;'%20d='M16,30.2C8.2,30.2,1.8,23.8,1.8,16S8.2,1.8,16,1.8S30.2,8.2,30.2,16S23.8,30.2,16,30.2z%20M16,2.8%20C8.7,2.8,2.8,8.7,2.8,16S8.7,29.2,16,29.2S29.2,23.3,29.2,16S23.3,2.8,16,2.8z'/%3e%3c/g%3e%3c/svg%3e)
Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Acquisitions News
10/21/2026
AcquisitionsDealsNewsletterRetina
Alcon Acquires Neurotech and its MacTel Treatment Encelto for $550 Million
Alcon announced Oct. 20 that it had acquired Neurotech Pharmaceuticals, maker of Encelto for macular telangiectasia Type 2 (MacTel), for $550 million. Alcon said that it might be required to make a...
8/20/2026
AcquisitionsDealsNewsletterRetina
Tarsus Enters Retina Sector with Two Acquisitions that Could Top $1 Billion
Tarsus Pharmaceuticals, maker of Xdemvy drops for Demodex blepharitis, has ventured into the retina sector recently with two acquisitions that could end up topping $1 billion. Tarsus said its deals...
5/14/2026
AcquisitionsDealsGlaucomaNewsletterRetina
Bayer to Acquire Perfuse in Deal Worth Up to $2.45 Billion
German drugmaker Bayer announced May 6 that it would acquire Perfuse Therapeutics in a deal worth up to $2.45 billion. Perfuse, of South San Francisco, California, is advancing PER-001 for glaucoma...
5/14/2026
AcquisitionsDealsDiagnosticNewsletter
Revenio Group to Acquire Visionix in $341 Million Deal
Finland’s Revenio Group, parent of ophthalmic diagnostic company iCare, announced April 13 that it would acquire France-based Visionix in a deal worth €290 million ($341 million). Revenio said that...
4/21/2026
AcquisitionsDealsNewsletterRetina
Cencora Expands Reach in Retina Care with Acquisition of EyeSouth Partners
Cencora’s agreement to purchase the retinal business of EyeSouth Partners for $1.1 billion is the company’s second major acquisition in an aggressive campaign to become a major, vertically integrat...
4/21/2026
AcquisitionsDealsFundingNewsletter
Fundraising Slows in Q1-2026 for Ophthalmic Firms
Market Scope identified 17 ophthalmic deals in Q1-2026, down from 21 in Q1-2025. Fundraising totals reached $856.6 million, a decline from $930.2 million in Q1-2025. The number of deals was below t...
4/21/2026
AcquisitionsDealsNewsletterRetina
Biogen to Acquire Apellis for $5.6 Billion with Eye Toward Growth
Biogen reported March 31 that it had agreed to acquire Apellis Pharmaceuticals, maker of Syfovre, for about $5.6 billion in cash to expand its portfolio of rare-disease medicines. Under the deal, e...
4/21/2026
AcquisitionsDealsInstrumentsNewsletter
Halma Acquires Surgistar to Augment MST’s Ophthalmic Instrument Portfolio
UK-based Halma, the parent of ophthalmic instrument maker MicroSurgical Technology (MST), announced April 13 that it had acquired Surgistar, of Vista, California, as an add-on to MST. No financial ...
1/21/2026
AcquisitionsDealsFundingNewsletter
Venture Capital in Ophthalmology Doubled in 2025 to Just Under $2 Billion
Venture capital investment in ophthalmology more than doubled from 2024 to 2025, totaling just under $2 billion in 2025 compared to $934.1 million in 2024. 2025 saw $1.1 billion in early-stage fund...
12/16/2025
AcquisitionsDealsDry EyeNewsletter
Iolyx Licenses Autoimmune Dry Eye Candidate to Théa in Deal Worth Up to $280 Million
Iolyx Therapeutics announced Dec. 3 that it had granted rights worldwide, excluding Asia, to France’s Laboratoires Théa to develop and commercialize ILYX-002, an immune-modulating eye drop candidat...
11/19/2025
AcquisitionsDealsNewsletterRetina
Lilly Makes Foray into Ophthalmic Gene Therapies with Adverum, MeiraGTx Deals
Drugmaker Eli Lilly made two significant moves recently to enter the arena of ophthalmic gene therapies, acquiring Adverum Biotechnologies in a deal worth up to $262 million, and licensing technolo...
11/19/2025
AcquisitionsCataractDealsNewsletterRetina
Amsurg Acquires ASC in South Carolina, Expanding Footprint in State
Amsurg, of Nashville, Tennessee, reported Oct. 28 that it had acquired Surgery Center of Conway, in Conway, South Carolina, its fourth center in the state. Amsurg, a leader in ASC services, said th...
11/19/2025
AcquisitionsDealsIOLNewsletterRefractive
STAAR Solicits New Bids Under Amended Deal with Alcon, Moves Shareholder Vote to Dec. 19
STAAR Surgical reported Nov. 7 that it had amended its merger agreement with Alcon to allow STAAR to solicit new buyers for 30 days under a new “go-shop” period ending Dec. 6. STAAR also delayed to...
9/12/2025
AcquisitionsBreakingDealsRefractive
EuroEyes Acquires Seven Betterview Clinics in Switzerland, Plus UK Assets
EuroEyes has acquired seven betterview refractive surgery clinics across Switzerland for CHF 12 million ($15 million, converted Sept. 2, 2025), plus betterview’s assets in the UK for an additional ...
8/20/2025
AcquisitionsDealsNewsletterRefractiveSurgical
Alcon’s Acquisition of STAAR Comes Amid Expansion Of Lens-Based Refractive Surgery
Alcon will acquire STAAR Surgical in a deal that values the manufacturer of the Implantable Collamer Lens (ICL) at $1.5 billion, the companies announced Aug. 5. The move is occurring at a time when...
7/22/2025
AcquisitionsDealsFundingNewsletter
Ophthalmic Venture Capital Continues to Bounce Back, Driven by Retinal Pharma
Venture capital investments accounted for 96 percent of ophthalmic deals in Q2-2025, with financing rounds totaling $590.7 million—the highest quarter since Q3-2023, when these transactions reached...
7/22/2025
AcquisitionsDealsNewsletterRetina
Alcon to Acquire LumiThera and Its Photobiomodulation Device for Dry AMD
Alcon announced July 7 that it intended to acquire LumiThera and its photobiomodulation (PBM) device that targets early and intermediate dry age-related macular degeneration (AMD). No financial det...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.